Single cell multi-omic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma

被引：0

作者：

Harrison, Simon ^{[1
,2
]}

Riley, Caroline Hasselbalch ^{[3
]}

Manier, Salomon ^{[4
]}

Yoon, Sung-Soo ^{[5
]}

Pinto, Antonio ^{[6
]}

Cazaubiel, Titouan ^{[7
]}

Guidetti, Anna ^{[8
]}

Popat, Rakesh ^{[9
]}

Touzeau, Cyrille ^{[10
]}

Ocio, Enrique ^{[11
]}

Offner, Fritz ^{[12
]}

Rodriguez-Otero, Paula ^{[13
]}

Rizzello, Ilaria ^{[14
,15
]}

Mateos, Maria-Victoria ^{[16
]}

Broeske, Ann-Marie ^{[17
]}

Dekhtiarenko, Iryna ^{[18
]}

Dimier, Natalie ^{[19
]}

Eckmann, Jan ^{[17
]}

Helms, Hans-Joachin ^{[20
]}

Jacob, Wolfgang ^{[17
]}

Schneider, Meike ^{[20
]}

Sleiman, Nassim ^{[20
]}

Weisser, Martin ^{[17
]}

Carlo-Stella, Carmelo ^{[21
,22
]}

机构：

[1] Univ Melbourne, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[2] Univ Melbourne, Royal Melbourne Hosp, Peter MacCallum Dept Oncol, Melbourne, Vic, Australia

[3] Rigshospitalet, Copenhagen, Denmark

[4] CHU Lille, Lille, France

[5] Seoul Natl Univ, Coll Med, Seoul, South Korea

[6] Ist Nazl Tumori IRCCS Fondazione G Pascale, Naples, Italy

[7] CHU Bordeaux, Bordeaux, France

[8] Ist Nazl Tumori, Milan, Italy

[9] NHS Univ Coll London Hosp, London, England

[10] CHU Nantes, Nantes, France

[11] Marques Valdecilla Univ Hosp, Santander, Spain

[12] Univ Ziekenhuis Gent, Ghent, Belgium

[13] Clin Univ Navarra, CIMA, CIBERONC, IDISNA, Pamplona, Spain

[14] Univ Bologna, Ist Ematol Seragnoli, IRCCS Azienda Osped, Bologna, Italy

[15] Univ Bologna, Bologna, Italy

[16] Univ Hosp Salamanca, IBSAL, CIC, CIBERONC, Salamanca, Spain

[17] Roche Innovat Ctr Munich, Penzberg, Germany

[18] Roche Innovat Ctr Zurich, Zurich, Switzerland

[19] Roche Innovat Ctr Welwyn, Welwyn Garden City, England

[20] Roche Innovat Ctr Basel, Basel, Switzerland

[21] Humanitas Univ, Dept Oncol & Hematol, Humanitas Canc Ctr, Humanitas Clin & Res Ctr, Rozzano, Italy

[22] Humanitas Univ, Dept Biomed Sci, Rozzano, Italy

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OA-04

引用

页码：S3 / S3

页数：1

共 50 条

[31] Safety and Efficacy of B-Cell Maturation Antigen (BCMA)-Specific Chimeric Antigen Receptor T Cells (CART-BCMA) with Cyclophosphamide Conditioning for Refractory Multiple Myeloma (MM)
Cohen, Adam D.
Garfall, Alfred L.
Stadtmauer, Edward A.
Lacey, Simon F.
Lancaster, Eric
Vogl, Dan T.
Weiss, Brendan M.
Ambrose, David E.
Nelson, Anne Marie
Chen, Fang
Plesa, Gabriela
Kulikovskaya, Irina
Gonzalez, Vanessa
Gupta, Minnal
Young, Regina M.
Dengel, Karen
O'keefe, Laura
Le, Samantha
Richardson, Celeste
Isaacs, Randi E.
Melenhorst, J. Joseph
Levine, Bruce L.
June, Carl H.
Milone, Michael C.
BLOOD, 2017, 130
[32] Population Pharmacokinetics of Orvacabtagene Autoleucel, an Autologous BCMA-Directed Chimeric Antigen Receptor T-cell Product, in Patients with Relapsed/Refractory Multiple Myeloma
Hu, Hongxiang
Li, Yan
Piasecki, Julia
Hosseyni, Daniela
Yan, Zhicheng
Liu, Xianghong
Ogasawara, Ken
Zhou, Simon
Cheng, Yiming
CLINICAL CANCER RESEARCH, 2025, 31 (06) : 1163 - 1171
[33] B cell maturation antigen-specific chimeric antigen receptor T cells for relapsed or refractory multiple myeloma: A meta-analysis
Gagelmann, Nico
Ayuk, Francis
Atanackovic, Djordje
Kroeger, Nicolaus
EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (04) : 318 - 327
[34] Allogeneic chimeric antigen receptor T-cells and multiple myeloma
Malard, Florent
HEMATOLOGIE, 2021, 27 : 13 - 18
[35] Cytotoxicity and exhaustion markers of chimeric antigen receptor T cells targeting BCMA in multiple myeloma cell lines between patients and healthy donors
Prasongtanakij, Somsak
Preedagasamzin, Sarinthip
Jittorntrum, Bunyada
Anurathapan, Usanarat
Puavilai, Teeraya
Niparuck, Pimjai
Chantrathammachart, Pichika
Piyajaroenkij, Thanakrit
Uaesoontrachoon, Kitipong
Uchibori, Ryosuke
Ozawa, Keiya
Ohmine, Ken
Hongeng, Suradej
EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (02) : 248 - 256
[36] Chimeric antigen receptor T-cell therapy for multiple myeloma
Wang, Zehua
Chen, Chen
Wang, Lei
Jia, Yongxu
Qin, Yanru
FRONTIERS IN IMMUNOLOGY, 2022, 13
[37] Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma
Hosen, Naoki
CANCERS, 2019, 11 (12)
[38] Chimeric antigen receptor T-cell therapy for multiple myeloma
Hosen, Naoki
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (04) : 530 - 534
[39] Chimeric antigen receptor T-cell therapies for multiple myeloma
Mikkilineni, Lekha
Kochenderfer, James N.
BLOOD, 2017, 130 (24) : 2594 - 2602
[40] Chimeric Antigen Receptor T-cell Therapy for Multiple Myeloma
Atrash, Shebli
Ali, Syed Abbas
Usmani, Saad Z.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (01): : 21 - 34

← 1 2 3 4 5 →